ResMed Inc. (RMD): Price and Financial Metrics


ResMed Inc. (RMD)

Today's Latest Price: $179.41 USD

1.38 (-0.76%)

Updated Oct 19 6:30pm

Add RMD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMD Stock Summary

  • Resmed Inc's market capitalization of $26,196,589,237 is ahead of 92.12% of US-listed equities.
  • The price/operating cash flow metric for Resmed Inc is higher than 87.8% of stocks in our set with a positive cash flow.
  • In terms of volatility of its share price, RMD is more volatile than just 6.98% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Resmed Inc are A, HOLX, CERN, LOGI, and VAR.
  • RMD's SEC filings can be seen here. And to visit Resmed Inc's official web site, go to www.resmed.com.

RMD Stock Price Chart Interactive Chart >

Price chart for RMD

RMD Price/Volume Stats

Current price $179.41 52-week high $208.99
Prev. close $180.79 52-week low $108.85
Day low $178.84 Volume 425,619
Day high $183.07 Avg. volume 680,762
50-day MA $175.39 Dividend yield 0.86%
200-day MA $169.79 Market Cap 26.00B

ResMed Inc. (RMD) Company Bio


ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.

RMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$179.41$74.96 -59%

Below please find a table outlining a discounted cash flow forecast for RMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Resmed Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Resmed Inc ended up being:

  • Interest coverage, a measure of earnings relative to interest payments, is 19.16 -- which is good for besting 84.83% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than only 14.56% of the free cash flow producing stocks we're observing.
  • RMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 44.16% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-59%
1%-59%
2%-59%
3%-58%
4%-58%
5%-57%

IONS, XRAY, JNJ, PKI, and ILMN can be thought of as valuation peers to RMD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


RMD Latest News Stream


Event/Time News Detail
Loading, please wait...

RMD Latest Social Stream


Loading social stream, please wait...

View Full RMD Social Stream

Latest RMD News From Around the Web

Below are the latest news stories about Resmed Inc that investors may wish to consider to help them evaluate RMD as an investment opportunity.

Digital Patient Monitoring Devices Market Size Will Accelerate Rapidly In The Near Future With Leading Key Vendors: Medtronic Plc, Omron Corporation, ResMed, AT&T, Inc, Welch Allyn, GE Healthcare, Zephyr Technology Corporation

Patient monitoring devices in this report refer to the sensors which are used in smart wearable devices. The patient monitoring devices market is driven by increasing demand for wearable for infants and continuously evolving sensor technology. With increasing personal care

OpenPR | October 2, 2020

Global Needle Guides Market Report Covers Growing Strategies Used By Top Key Players || ResMed, BD, Argon Medical Devices, Seimens

The motive of this strategic research report entitled Global Needle Guides Market Which offers company accounts, industry investors, and industry members with consequential insights to enable them to make reliable strategic decisions regarding the opportunities in the global Needle Guides

OpenPR | September 30, 2020

Global $940 Million High Performance Doors Market Outlook to 2025: Major Players are Koninklijke Philips, ResMed, Boston Scientific, Medtronic, Connect America

DUBLIN, Sept. 30, 2020 /PRNewswire/ -- The "High Performance Doors Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The high performance doors market by revenue is expected to grow at a CAGR of approx. 4% and achieve an…

PR Newswire | September 30, 2020

MIT Leaders for Global Operations announces new industry partnership with ResMed

CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- The MIT Leaders for Global Operations (LGO) program announced today that ResMed, a global digital health and connected medical device company, has become the newest member of its industry partnership. This addition brings the partner company…

PR Newswire | September 9, 2020

ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever

SAN DIEGO--(BUSINESS WIRE)---- $RMD #CPAP--ResMed’s first nasal memory foam cushion enhances patients’ comfort and convenience, doesn’t need cleaning when replaced on an appropriate schedule.

Business Wire | September 1, 2020

Read More 'RMD' Stories Here

RMD Price Returns

1-mo 5.53%
3-mo -12.04%
6-mo 11.99%
1-year 38.03%
3-year 135.89%
5-year 245.23%
YTD 16.55%
2019 37.85%
2018 36.38%
2017 39.06%
2016 18.01%
2015 -2.29%

RMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7574 seconds.